跳至主要内容
临床试验/EUCTR2016-003684-19-DE
EUCTR2016-003684-19-DE进行中(未招募)1 期

Xenon-anesthesia on patients undergoing major liver-resection: randomized controlled trial - Xe-Liv

RWTH Aachen, represented by the Rector, himself represented by the Dean of the Medical Faculty0 个研究点目标入组 74 人开始时间: 2017年11月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.= 3 segment resection
  • 2.= 18 years
  • 3.Both gender
  • 4.ASA I-III
  • 5.Written informed consent prior to study participation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 74
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 74

排除标准

  • 1.Severe pulmonary or airway disease
  • 2.Severe liver disease, accompanied by a Child–Pugh class >A
  • 3.Allergy/hypersensitivity to study medications
  • 4.ASA > III
  • 5.Patients susceptible to malignant hyperthermia
  • 6.Women who are pregnant, breast-feeding or women of childbearing potential not using adequate contraceptive methods
  • 7.Patients with elevated intracranial pressure
  • 8.Patients legally unable to give written informed consent.
  • 9.Patients with preeclampsia or eclampsia
  • 10.Patients with a risk of high oxygen demand
  • 11.Patients with seriously impaired cardiac function
  • 12.All contraindications for xenon anesthesia according to the summary of product characteristics LENOXe
  • 13. Patient participates in a parallel interventional clinical trial during this study or receives an investigational drug within 30 days prior to inclusion into this study

研究者

发起方
RWTH Aachen, represented by the Rector, himself represented by the Dean of the Medical Faculty

相似试验

Xenon-anesthesia on patients undergoing major... | 临床试验